Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study

被引：0
|
作者：
Ying Li
Chengzhi Lv
Lin Dang
Bingjiang Lin
Juan Tao
Chunlei Zhang
Xiaoyong Zhou
Han Ma
Yi Lu
Rong Chen
Jinnan Li
Guanshen Dou
Yunsheng Liang
Yanhua Liang
Yuling Shi
机构：
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Dalian Dermatosis Hospital,Department of Dermatology
[3] Longgang Central Hospital of Shenzhen,Department of Dermatology
[4] Ningbo First Hospital,Department of Dermatology
[5] Huazhong University of Science and Technology (HUST),Department of Dermatology, Union Hospital, Tongji Medical College
[6] Peking University Third Hospital,Department of Dermatology
[7] Department of Dermatology,Department of Dermatology
[8] Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Dermatology, Dermatology Hospital
[9] Eli Lilly and Company,Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital
[10] Southern Medical University,undefined
[11] Southern Medical University,undefined
来源：
Dermatology and Therapy | 2024年 / 14卷
关键词：
Effectiveness; Ixekizumab; Moderate-severe plaque psoriasis; Special body areas; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 918
页数：11
相关论文
共 50 条
  • [1] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Li, Ying
    Lv, Chengzhi
    Dang, Lin
    Lin, Bingjiang
    Tao, Juan
    Zhang, Chunlei
    Zhou, Xiaoyong
    Ma, Han
    Lu, Yi
    Chen, Rong
    Li, Jinnan
    Dou, Guanshen
    Liang, Yunsheng
    Liang, Yanhua
    Shi, Yuling
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (04) : 907 - 918
  • [2] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
    Ying, Li
    Suyun, Ji
    Yanhua, Liang
    Yunsheng, Liang
    Li, Deng
    Lin, Dang
    Chengzhi, Lv
    Bingjiang, Lin
    Furen, Zhang
    Wendi, Shi
    Jinnan, Li
    Yu, Dong
    Guanshen, Dou
    Shi, Yuling
    [J]. ADVANCES IN THERAPY, 2023, 40 (12) : 5464 - 5474
  • [3] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
    Li Ying
    Ji Suyun
    Liang Yanhua
    Liang Yunsheng
    Deng Li
    Dang Lin
    Lv Chengzhi
    Lin Bingjiang
    Zhang Furen
    Shi Wendi
    Li Jinnan
    Dong Yu
    Dou Guanshen
    Yuling Shi
    [J]. Advances in Therapy, 2023, 40 : 5464 - 5474
  • [4] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [5] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Andrea Chiricozzi
    Martina Burlando
    Giacomo Caldarola
    Andrea Conti
    Giovanni Damiani
    Clara De Simone
    Valentina Dini
    Piergiorgio Malagoli
    Francesca Peccerillo
    Concetta Potenza
    Emanuele Scala
    Nevena Skroza
    Anna Balato
    [J]. American Journal of Clinical Dermatology, 2020, 21 : 441 - 447
  • [6] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Chiricozzi, Andrea
    Burlando, Martina
    Caldarola, Giacomo
    Conti, Andrea
    Damiani, Giovanni
    De Simone, Clara
    Dini, Valentina
    Malagoli, Piergiorgio
    Peccerillo, Francesca
    Potenza, Concetta
    Scala, Emanuele
    Skroza, Nevena
    Balato, Anna
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 441 - 447
  • [7] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [8] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [9] Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA
    Thaci, Diamant
    Foley, Peter
    Richardson, Craig
    Shi, Yulin
    Kasparek, Torben
    Fang, Juanzhi
    Augustin, Matthias
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB193 - AB193
  • [10] Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
    Bucur, Stefana
    Serban, Elena-Daniela
    Ileanu, Bogdan Vasile
    Costache, Raluca Simona
    Nicolescu, Alin Codrut
    Constantin, Traian
    Costache, Daniel Octavian
    Constantin, Maria -Magdalena
    [J]. PSORIASIS-TARGETS AND THERAPY, 2024, 14 : 79 - 86
12345